
VolitionRx Limited VNRX
€ 0.20
-8.22%
Quartalsbericht 2025-Q3
hinzugefügt 13.11.2025
VolitionRx Limited ROA 2011-2025 | VNRX
ROA Jährlich VolitionRx Limited
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -289.99 | -127.64 | -167.25 | -98.18 | - | -75.61 | -102.97 | -100.99 | -48.14 | -123.58 | -239.25 | -179.24 | - | - |
Alle Zahlen in USD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| -48.14 | -289.99 | -141.17 |
ROA Vierteljährlich VolitionRx Limited
| 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -265.53 | -228.41 | -210.25 | -143.9 | -190.75 | -191.33 | -171.96 | -130.69 | -164.16 | -150.77 | -147.87 | -89.59 | -113.52 | -103.99 | -88.05 | -54.87 | -71.45 | -64.1 | -67.57 | -58.27 | -77.91 | -80.96 | -81.2 | -58.91 | -84.5 | -90.46 | -97.2 | -78.46 | -105.07 | -106.09 | -103.52 | -73.21 | -87.28 | -74.72 | -62.97 | -36.07 | -74.49 | -98.84 | -111.17 | -88.74 | -260.42 | -393.69 | -345.64 | -211.81 | -256.51 | -129.52 | -203.9 | -139.12 | -256.67 | -329.52 | -320.95 | -195.73 | -271.05 | -228.81 | -215.31 | -118.75 | -75.31 | -28.51 | -14.93 |
Alle Zahlen in USD-Währung
Indikatorspanne aus vierteljährlicher Berichterstattung
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| -14.93 | -393.69 | -141.95 |
ROA anderer Aktien in der Diagnostik & Forschung
| Name | ROA | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
|
Centogene N.V.
CNTG
|
-51.41 | - | -6.23 % | $ 30.6 M | ||
|
Akumin
AKU
|
-8.88 | - | -17.87 % | $ 25.9 M | ||
|
Brainsway Ltd.
BWAY
|
-8.53 | $ 17.27 | 1.8 % | $ 99.4 M | ||
|
Burning Rock Biotech Limited
BNR
|
-34.96 | $ 15.82 | 0.44 % | $ 170 M | ||
|
Accelerate Diagnostics
AXDX
|
-22.47 | - | -61.36 % | $ 2.46 M | ||
|
Biocept
BIOC
|
-103.93 | - | -13.05 % | $ 7.29 M | ||
|
BioNano Genomics
BNGO
|
-146.1 | $ 1.55 | -4.63 % | $ 1.97 M | ||
|
Oxford Immunotec Global PLC
OXFD
|
-0.77 | - | - | $ 562 M | ||
|
DarioHealth Corp.
DRIO
|
-61.65 | $ 12.14 | 2.1 % | $ 344 M | ||
|
DexCom
DXCM
|
8.64 | $ 65.83 | -1.69 % | $ 25.4 B | ||
|
Castle Biosciences
CSTL
|
3.43 | $ 39.06 | 1.11 % | $ 1.08 B | ||
|
Chembio Diagnostics
CEMI
|
-37.2 | - | 0.22 % | $ 16.8 M | ||
|
Exact Sciences Corporation
EXAS
|
-14.58 | $ 101.64 | 0.14 % | $ 18.8 B | ||
|
Danaher Corporation
DHR
|
5.03 | $ 227.72 | 0.54 % | $ 166 B | ||
|
Fulgent Genetics
FLGT
|
-3.5 | $ 27.0 | -0.52 % | $ 816 M | ||
|
Global Cord Blood Corporation
CO
|
5.87 | - | - | $ 399 M | ||
|
Fluidigm Corporation
FLDM
|
-16.33 | - | 1.08 % | $ 308 M | ||
|
Genetic Technologies Limited
GENE
|
-34.28 | - | - | $ 7.1 B | ||
|
Genetron Holdings Limited
GTH
|
-33.12 | - | 0.12 % | $ 80.1 M | ||
|
DermTech
DMTK
|
-82.74 | - | -11.32 % | $ 2.94 M | ||
|
PRA Health Sciences, Inc.
PRAH
|
4.72 | - | - | $ 10.7 B | ||
|
CareDx, Inc
CDNA
|
-40.76 | $ 19.98 | -2.82 % | $ 1.07 B | ||
|
Celcuity
CELC
|
-45.6 | $ 101.67 | -3.4 % | $ 4.01 B | ||
|
Enzo Biochem
ENZ
|
-30.41 | - | -8.98 % | $ 14.8 K | ||
|
Anixa Biosciences
ANIX
|
-58.14 | $ 3.3 | -7.82 % | $ 105 K | ||
|
Co-Diagnostics
CODX
|
-37.07 | $ 0.29 | -14.47 % | $ 8.51 M | ||
|
IQVIA Holdings
IQV
|
5.1 | $ 222.75 | 0.24 % | $ 40.4 B | ||
|
Guardant Health
GH
|
-29.37 | $ 103.7 | 1.6 % | $ 12.7 B | ||
|
Aspira Women's Health
AWH
|
-156.39 | - | -6.19 % | $ 10.5 M | ||
|
Heska Corporation
HSKA
|
-3.4 | - | - | $ 1.31 B | ||
|
HTG Molecular Diagnostics
HTGM
|
-121.47 | - | -20.0 % | $ 1.06 M | ||
|
Illumina
ILMN
|
-19.4 | $ 134.4 | -0.35 % | $ 21.4 B | ||
|
Charles River Laboratories International
CRL
|
0.29 | $ 197.62 | 2.4 % | $ 10.2 B | ||
|
Quotient Limited
QTNT
|
-50.51 | - | -11.32 % | $ 1.1 M | ||
|
Mettler-Toledo International
MTD
|
26.64 | $ 1 410.02 | 1.15 % | $ 29.9 B | ||
|
Quest Diagnostics Incorporated
DGX
|
5.39 | $ 183.96 | 0.79 % | $ 20.4 B | ||
|
NeoGenomics
NEO
|
-4.81 | $ 12.03 | 1.48 % | $ 1.52 B | ||
|
Neogen Corporation
NEOG
|
-31.71 | $ 6.85 | -0.22 % | $ 1.49 B | ||
|
Biodesix
BDSX
|
-44.15 | $ 7.63 | -2.8 % | $ 989 M | ||
|
Myriad Genetics
MYGN
|
-12.39 | $ 7.04 | -2.36 % | $ 638 M | ||
|
Laboratory Corporation of America Holdings
LH
|
4.06 | $ 262.89 | -0.48 % | $ 22.1 B | ||
|
ICON Public Limited Company
ICLR
|
4.69 | $ 184.38 | -1.18 % | $ 15.2 B | ||
|
IDEXX Laboratories
IDXX
|
26.96 | $ 698.77 | -0.77 % | $ 57.6 B | ||
|
Lantheus Holdings
LNTH
|
15.78 | $ 66.4 | -0.33 % | $ 4.59 B | ||
|
Agilent Technologies
A
|
11.3 | $ 140.3 | 0.46 % | $ 42.7 B | ||
|
Biomerica
BMRA
|
-83.65 | $ 2.48 | -2.65 % | $ 5.7 M | ||
|
Bioventus
BVS
|
-19.27 | $ 7.49 | -0.86 % | $ 469 M | ||
|
Check-Cap Ltd.
CHEK
|
-6670.82 | - | - | $ 9.42 M | ||
|
Pacific Biosciences of California
PACB
|
-17.57 | $ 2.13 | 0.24 % | $ 540 M | ||
|
Motus GI Holdings
MOTS
|
-178.14 | - | -34.28 % | $ 263 K |